This inventor holds 1 USPTO granted patent. Top assignee: Neuren Pharmaceuticals Limited. Active years: 2007.
Company Filing History:
Years Active: 2007
Title: David Charles Batchelor: Innovator in Immunogenic Detection
Introduction
David Charles Batchelor is a notable inventor based in Auckland, New Zealand. He has made significant contributions to the field of immunology, particularly in the detection of weakly immunogenic analytes. His work has implications for both research and clinical applications.
Latest Patents
David holds a patent for "Methods for detecting weakly immunogenic analytes." This patent describes how GPE antibodies recognize GPE with high specificity. When utilized in a radioimmunoassay, these antibodies reliably measure the concentration of GPE. Furthermore, they may be used to extend the half-life of GPE both in vivo and in vitro, as well as in methods of purifying the GPE receptor. His innovative approach includes two methods of rpHPLC that accurately revolve GPE based on its hydrophobicity. David has 1 patent to his name.
Career Highlights
David is currently employed at Neuren Pharmaceuticals Limited, where he continues to advance his research in immunology. His work at this company has allowed him to explore new methodologies and applications for his inventions.
Collaborations
David has collaborated with notable colleagues, including Gregory Brian Thomas and Bernhard Hermann Heinrich Breier. These partnerships have enriched his research and contributed to the development of innovative solutions in the field.
Conclusion
David Charles Batchelor is a distinguished inventor whose work in immunogenic detection has the potential to impact various scientific and medical fields. His contributions continue to pave the way for advancements in immunology.